InsiderTrades.com logo
John Neuman net worth and biography
  • Phone
  • Email
  • Website

John Neuman Biography and Net Worth

Director of SeaStar Medical

John Neuman retired from The Dow Chemical Company in 2023 following 30 years of service, most recently as Vice President of Global Financial Accounting. In this position, he directed a team of approximately 350 professionals with responsibilities for financial accounting and reporting for a global network of more than 400 legal entities, including SEC filings. His tenure at Dow included finance integration and reporting responsibilities for several transactions, including the Rohm & Haas and Dow Corning acquisitions, and the Dow/DuPont merger. Prior to joining Dow, Mr. Neuman was an audit manager for Deloitte & Touche LLP. He holds a degree in accounting from Michigan State University and previously served as a member of the Michigan State University External Advisory Board for the Department of Accounting and Information Systems. He is a Certified Public Accountant (inactive).

What is John Neuman's net worth?

The estimated net worth of John Neuman is at least $36.66 thousand as of June 24th, 2025. Mr. Neuman owns 8,000 shares of SeaStar Medical stock worth more than $36,656 as of October 2nd. This net worth evaluation does not reflect any other investments that Mr. Neuman may own. Learn More about John Neuman's net worth.

How do I contact John Neuman?

The corporate mailing address for Mr. Neuman and other SeaStar Medical executives is 3513 Brighton Blvd, Suite 410, Denver, CO, 80216. SeaStar Medical can also be reached via phone at 844-427-8100 and via email at [email protected]. Learn More on John Neuman's contact information.

Has John Neuman been buying or selling shares of SeaStar Medical?

John Neuman has not been actively trading shares of SeaStar Medical during the last ninety days. Most recently, on Tuesday, June 24th, John Neuman bought 4,000 shares of SeaStar Medical stock. The stock was acquired at an average cost of $3.60 per share, with a total value of $14,400.00. Following the completion of the transaction, the director now directly owns 8,000 shares of the company's stock, valued at $28,800. Learn More on John Neuman's trading history.

Who are SeaStar Medical's active insiders?

SeaStar Medical's insider roster includes Jennifer Baird (Director), John Neuman (Director), and Kenneth Van Heel (Director). Learn More on SeaStar Medical's active insiders.

Are insiders buying or selling shares of SeaStar Medical?

In the last year, SeaStar Medical insiders bought shares 3 times. They purchased a total of 2,620 shares worth more than $8,535.50. The most recent insider tranaction occured on August, 18th when CFO Michael Messinger bought 750 shares worth more than $2,452.50. Insiders at SeaStar Medical own 0.7% of the company. Learn More about insider trades at SeaStar Medical.

Information on this page was last updated on 8/18/2026.

John Neuman Insider Trading History at SeaStar Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/24/2025Buy4,000$3.60$14,400.008,000View SEC Filing Icon  
See Full Table

John Neuman Buying and Selling Activity at SeaStar Medical

This chart shows John Neuman's buying and selling at SeaStar Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SeaStar Medical Company Overview

SeaStar Medical logo
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Read More

Today's Range

Now: $4.56
Low: $3.69
High: $4.70

50 Day Range

MA: $3.28
Low: $2.88
High: $3.94

2 Week Range

Now: $4.56
Low: $2.07
High: $7.35

Volume

259,359 shs

Average Volume

106,332 shs

Market Capitalization

$20.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A